From February 18, 2024 to March 31, 2024, the company has repurchased 392,167 shares, representing 0.98% for CNY 11.7 million. With this, the company has completed the repurchase of 392,167 shares, representing 0.98% for CNY 11.7 million under the buyback announced on February 19, 2024.
Shanghai Rendu Biotechnology Co., Ltd.
Equities
688193
CNE1000059K5
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25 CNY | -0.99% | -3.55% | -44.59% |
1st Jan change | Capi. | |
---|---|---|
-44.59% | 139M | |
-6.68% | 179B | |
-5.20% | 98.84B | |
-5.38% | 65.34B | |
+15.46% | 45.41B | |
-6.47% | 44.94B | |
+9.74% | 43.76B | |
+14.01% | 29.01B | |
+19.39% | 25.65B | |
-6.53% | 23.32B |
- Stock Market
- Equities
- 688193 Stock
- News Shanghai Rendu Biotechnology Co., Ltd.
- Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.